Clinical trial

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

NCT02534896

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Treatment I Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Treatment II Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Treatment III Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-11-01

PhasePHASE3

Conditions

Active Rheumatoid Arthritisunresolved

Interventions

Treatment IDRUG

Treatment IIDRUG

Treatment IIIDRUG

Sponsors & collaborators

Sun Pharmaceutical Industries Limitedlead sponsor

Mapped research locations

BrusselsBelgium5 AmsterdamNetherlands2 RotterdamNetherlands2 LeuvenBelgium1 LiègeBelgium1 UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02534896 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.